• Ginsenoside Rg1: From Phenotype to Causal Assay

  2026-08-19

  Ginsenoside Rg1 is examined here as a causal assay tool rather than only a neuroprotective candidate. Learn how to connect behavioral, synaptic, inflammatory, gut-barrier, and regulatory T-cell readouts while preserving chemical and evidentiary rigor.

• EZ Cap™ Human PTEN mRNA: Evidence & Workflow

  2026-08-18

  EZ Cap™ Human PTEN mRNA is a Cap 1, poly(A)-tailed tumor suppressor gene mRNA for transient human PTEN expression. Its defined 1467-nucleotide format and research-use handling profile support cancer research, pathway studies, and experimental mRNA delivery development.

• Dabigatran etexilate in Thrombin Assay Workflows

  2026-08-18

  Dabigatran etexilate provides a practical tool for linking thrombin biochemistry with plasma coagulation and platelet studies. This workflow-focused guide covers prodrug handling, concentration design, orthogonal readouts, and troubleshooting for anticoagulant research.

• SR-202 Workflows for PPARγ Mechanism Studies

  2026-08-17

  SR-202 provides a selective way to test whether PPARγ activity connects macrophage polarization, adipocyte differentiation, and metabolic phenotypes. This practical guide converts the reference study into cell-based workflows, controls, troubleshooting checkpoints, and translational assay strategies.

• Merbromin Inhibits SARS-CoV-2 3CLpro

  2026-08-17

  A high-throughput study screened approximately 6,000 compounds and identified Merbromin as a selective, mixed-type inhibitor of the SARS-CoV-2 3-chymotrypsin-like protease, 3CLpro. Kinetic, surface-binding, and docking analyses support a multi-site inhibition model, while also defining the compound as an early antiviral screening lead rather than a clinically validated antiviral.

• FAK Inhibitor 14: A Mechanistic Assay Guide

  2026-08-16

  Explore how FAK Inhibitor 14 can clarify the FAK signaling pathway in cancer biology research. This guide connects product handling with causal assay design for cell migration inhibition and tumor metastasis research.

• L-NAME Hydrochloride: From NO Biology to Translation

  2026-08-15

  A mechanistic and strategic guide to using L-NAME Hydrochloride as an orthogonal NOS perturbation tool in vascular tone regulation studies, hypertension research, and inflammation-focused translational models.

• Imipenem Workflows for Resistance Research

  2026-08-14

  Imipenem supports more than routine antibacterial screening: it can connect susceptibility testing with plasmid-transfer surveillance and immune-cell assays. This practical guide translates recent CREC transmission findings into reproducible, research-use-only workflows with troubleshooting strategies for aqueous preparation, phenotype interpretation, and cross-domain validation.

• FITC Goat Anti-Rabbit IgG (H+L) Antibody Workflow

  2026-08-14

  Build sensitive rabbit-primary detection workflows for immunofluorescence, flow cytometry, and fluorescent tissue imaging with a FITC-conjugated secondary. This practical guide connects assay design and troubleshooting to the IL-11 pulmonary fibrosis study while clearly separating validated product specifications from optimization starting points.

• EdU Imaging Kits (Cy3) for HCC S-Phase Studies

  2026-08-13

  EdU Imaging Kits (Cy3) provide a non-denaturing way to connect S-phase DNA synthesis with the NPC1/USP7/p53 biology of hepatocellular carcinoma. This article translates the reference study into practical imaging and flow-cytometry decisions while clarifying what an EdU endpoint can—and cannot—prove.

• Perospirone Inhibits Coronary Kv Channels

  2026-08-13

  The reference study identifies a previously unrecognized vascular ion-channel action of perospirone: concentration-dependent inhibition of Kv currents in freshly isolated rabbit coronary arterial smooth muscle cells. Its electrophysiological and pharmacological analyses implicate Kv1.5 channels and provide a mechanistic basis for investigating cardiovascular consequences alongside established serotonergic and dopaminergic effects.

• Nuclear mTORC1 and the TerminaTOR Strategy

  2026-08-12

  The reference study introduces TerminaTOR, a genetically encoded inhibitor that can be directed to distinct subcellular pools of mTORC1. By comparing lysosomal and nuclear targeting, the authors show that nuclear mTORC1 has a specialized role in regulating transcription of CCAAT motif-containing genes, separating this function from canonical lysosomal signaling and autophagy control.

• HOXC8, Caspase-1, and Pyroptosis in NSCLC

  2026-08-12

  The reference study shows that HOXC8 supports non-small cell lung carcinoma by repressing caspase-1 transcription through HDAC1/2 recruitment, thereby limiting pyroptotic cell death. Its combination of pharmacologic, molecular, and in vivo experiments identifies an ASC-independent caspase-1 pathway and suggests a mechanistic framework for studying tumor-associated inflammation.

• AICAR Phosphate: Context-Aware AMPK Assays

  2026-08-11

  AICAR phosphate (Acadesine) is more than an AMPK activator: it is a context-sensitive perturbation tool for separating metabolic signaling from apoptosis. This guide connects B-CLL cell-death assays with hypoxia-driven choroid plexus biology and provides practical strategies for interpreting pathway, mitochondrial, and viability readouts.

• Clozapine N-oxide: Mapping Cortical State

  2026-08-11

  Clozapine N-oxide (CNO) can do more than activate DREADDs: it can help separate cell-type-specific cortical activity from behavioral outcomes. This article translates recent chronic migraine findings into practical chemogenetic assay decisions for neuronal activity modulation.

8057 records 6/538 page Previous Next First page 上5页 678910 下5页 Last page